Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases
- PMID: 20084712
Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases
Abstract
Aim: To compare a single 8 Gy fraction with conventional regimen of 40 Gy in 20 fractions as a palliative treatment to patients with bone metastasis and reducing the treatment burden for both the patients and Hospital Staff.
Methods: One hundred and seven patients with painful localized bone metastases requiring palliative radiotherapy were entered into a prospective randomized trial comparing 8 Gy single fraction (SF group) with 40 Gy in 20 fractions, five fractions/week (CF group). The primary tumor was in the breast in (48.1%) of the patients, in the lung in (20.6%) in the prostate in (17.6%), and in other sites in (13.7%). Bone metastases were located in the spine (42.2%), pelvis (29.4%) limbs (21.6%), and other sites (6.8%). Pain relief was measured by visual analogue scale (VAS) and also by analgesic requirement. Evaluation was performed before and at 2 weeks then every 4 weeks for 24 weeks after treatment. A total of 102 patients were evaluable for response; 50 in the SF group and 52 in the CF group.
Results: There were no significant diferences in the frequency or duration of pain relief between the two study groups. In both groups, the maximum benefit was achieved at 8 weeks after treatment; 41 patients (82%) in SF group and (44%) of those in the CF group. The frequency of pain by > or =50% on VAS. Complete pain relief was reported in (44%) of those in the CF group. The frequency of pain relief did not differ between the two groups with respect to the primary tumor, the metastatic sites, and the performance status, but for patients as a whole, there was a significantly lower response rate for lung cancer patients (61.9%) in comparision to patients with breast (91.8%) and prostate (100%) cancer. The median duration of pain relief was 12 weeks in the SF group and 13.5 weeks in CF group. During follow-up, 7 patients (6 in SF group and one in CF group) had their bone metastases re-irradiated. Six of these re-irradiated patients also achieved pain relief.
Conclusion: This study indicates that a single fraction of 8 Gy is as effective as 40 Gy in 20 fractions for the palliation of painful bone metastases. Single fraction schedule may be preferred for patient convenience and an option for re-treatment in the case of recurrent pain.
Similar articles
-
8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.Radiother Oncol. 1999 Aug;52(2):111-21. Radiother Oncol. 1999. PMID: 10577696 Clinical Trial.
-
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.J Natl Cancer Inst. 2005 Jun 1;97(11):798-804. doi: 10.1093/jnci/dji139. J Natl Cancer Inst. 2005. PMID: 15928300 Clinical Trial.
-
Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.Radiother Oncol. 2006 Jun;79(3):278-84. doi: 10.1016/j.radonc.2006.05.006. Epub 2006 Jun 21. Radiother Oncol. 2006. PMID: 16793154 Clinical Trial.
-
Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):594-605. doi: 10.1016/s0360-3016(02)04147-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12573746 Review.
-
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.Eur J Cancer. 2012 Mar;48(5):678-86. doi: 10.1016/j.ejca.2011.12.023. Epub 2012 Feb 15. Eur J Cancer. 2012. PMID: 22341993 Review.
Cited by
-
Bias due to statistical handling of death and reirradiation in the assessment of duration of response after palliative radiotherapy: a scoping review and analysis of clinical data.Br J Radiol. 2023 Jan 1;96(1141):20220398. doi: 10.1259/bjr.20220398. Epub 2022 Oct 10. Br J Radiol. 2023. PMID: 36125225 Free PMC article.
-
Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.JAMA Netw Open. 2022 Sep 1;5(9):e2231930. doi: 10.1001/jamanetworkopen.2022.31930. JAMA Netw Open. 2022. PMID: 36136335 Free PMC article.
-
Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness.Cancer Manag Res. 2014 Nov 25;6:451-7. doi: 10.2147/CMAR.S44940. eCollection 2014. Cancer Manag Res. 2014. PMID: 25473313 Free PMC article. Review.
-
Burden of skeletal-related events in prostate cancer: unmet need in pain improvement.Support Care Cancer. 2015 Jan;23(1):237-47. doi: 10.1007/s00520-014-2437-3. Epub 2014 Oct 2. Support Care Cancer. 2015. PMID: 25270847 Review.
-
Frequency of Complicated Symptomatic Bone Metastasis Over a Breadth of Operational Definitions.Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):800-810. doi: 10.1016/j.ijrobp.2019.11.033. Epub 2019 Dec 2. Int J Radiat Oncol Biol Phys. 2020. PMID: 31805367 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical